Cognito and Neurotech Reach a Critical Stage with $105 Million
Cognito raises $105M to advance FDA pivotal trial, expand Spectris neurotech platform, and target Alzheimer’s, Parkinson’s, and other CNS disorders.
Loading...
Cognito raises $105M to advance FDA pivotal trial, expand Spectris neurotech platform, and target Alzheimer’s, Parkinson’s, and other CNS disorders.
